A Phase 2/3 Study of Brepocitinib in Adults With Cutaneous Sarcoidosis

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03536884 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03598790 ·Status: COMPLETED ·Phase: PHASE3

Bimekizumab in Plaque Psoriasis

NCT06336343 ·Status: COMPLETED ·Phase: PHASE4

Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis

NCT04064242 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis

NCT06191042 ·Status: COMPLETED ·Phase: PHASE1

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

NCT04036435 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis

NCT00731757 ·Status: WITHDRAWN ·Phase: PHASE2

A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)

NCT02394561 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis

NCT02029495 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis

NCT04680975 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

NCT03230292 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03412747 ·Status: COMPLETED ·Phase: PHASE3

Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers

NCT02362789 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

NCT03010527 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice

NCT04517669 ·Status: COMPLETED

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

NCT06176508 ·Status: RECRUITING ·Phase: PHASE2

Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT03982394 ·Status: COMPLETED

Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis

NCT03504852 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

NCT06011733 ·Status: COMPLETED ·Phase: PHASE3

Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris

NCT03342573 ·Status: COMPLETED ·Phase: PHASE1

Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

NCT05030415 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03370133 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

NCT02024646 ·Status: COMPLETED ·Phase: PHASE3

Acthar Gel in Participants With Pulmonary Sarcoidosis

NCT03320070 ·Status: COMPLETED ·Phase: PHASE4

POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis

NCT05932654 ·Status: COMPLETED ·Phase: PHASE2